These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1061 related articles for article (PubMed ID: 30484833)
1. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833 [TBL] [Abstract][Full Text] [Related]
2. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry. Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545 [TBL] [Abstract][Full Text] [Related]
3. Veterans Affairs Medical Center Racial and Ethnic Composition and Initiation of Anticoagulation for Atrial Fibrillation. Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Litam TMA; Boyer TL; Gellad WF; Fine MJ JAMA Netw Open; 2024 Jun; 7(6):e2418114. PubMed ID: 38913375 [TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries. Reynolds KR; Khosrow-Khavar F; Dave CV JAMA Netw Open; 2024 May; 7(5):e249465. PubMed ID: 38709533 [TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL; Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367 [TBL] [Abstract][Full Text] [Related]
6. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System. Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358 [TBL] [Abstract][Full Text] [Related]
7. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities. Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655 [TBL] [Abstract][Full Text] [Related]
8. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755 [TBL] [Abstract][Full Text] [Related]
9. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation. Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325 [TBL] [Abstract][Full Text] [Related]
10. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Jackson LR; Kim S; Blanco R; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Kowey PR; Mahaffey KW; Hylek EM; Peterson ED; Piccini JP; Am Heart J; 2020 Aug; 226():85-93. PubMed ID: 32526533 [TBL] [Abstract][Full Text] [Related]
11. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
12. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry. Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265 [TBL] [Abstract][Full Text] [Related]
13. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study. Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154 [TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448 [TBL] [Abstract][Full Text] [Related]
15. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation. Derington CG; Goodrich GK; Xu S; Clark NP; Reynolds K; An J; Witt DM; Smith DH; O'Keeffe-Rosetti M; Lang DT; Ho PM; Cheetham TC; Comer AC; King JB JAMA Netw Open; 2023 Jul; 6(7):e2321971. PubMed ID: 37410461 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP; Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380 [TBL] [Abstract][Full Text] [Related]
17. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry. Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A; Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823 [TBL] [Abstract][Full Text] [Related]
18. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320 [TBL] [Abstract][Full Text] [Related]
19. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]). Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP; Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354 [TBL] [Abstract][Full Text] [Related]
20. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation. Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]